Oxidative DNA damage in the Parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1196-1203

  Alam, Z I ^a   Jenner, A ^a   Daniel, S E ^b   Lees, A J ^b   Cairns, N ^a   Marsden, C D ^b   Jenner, P ^a   Halliwell, B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

8 Hydroxyguanosine; Oxidative damage; Parkinson's disease; Substantia nigra

Indexed keywords

8 HYDROXYGUANINE; SUPEROXIDE DISMUTASE;

ARTICLE; CELL DEATH; DEAMINATION; DNA DAMAGE; DOPAMINE UPTAKE; ELECTRON TRANSPORT; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

PARKINSONIA;

EID: 0030878073     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031196.x     Document Type: Article

References (34)

1. Ahlskog J. E., Uitti R. J., Low P. A., Tyce G. M., Nickander K. K., Peterson R. C., and Kokmen E. (1995) No evidence for systemic oxidant stress in Parkinson's disease. Mov. Disord. 10, 566-573.
2. Aruoma O. I., Halliwell B., Gajewski E., and Dizdaroglu M. (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J. Biol. Chem. 264, 20509-20512.
3. Aruoma O. I., Halliwell B., Gajewski E., and Dizdaroglu M. (1991) Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem. J. 273, 601-604.
4. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
5. Dizdaroglu M. (1994) Chemical determination of oxidative DNA damage by gas chromatography-mass spectrometry. Methods Enzymol. 234, 3-16.
6. Dizdaroglu M., Rao G., Halliwell B., and Gajewski E. (1991a) Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem. Biophys. 285, 317-324.
7. Dizdaroglu M., Nackerdien Z., Chao B. C., Gajewski E., and Rao G. (1991b) Chemical nature of in vivo DNA base damage in hydrogen peroxide-treated mammalian cells. Arch. Biochem. Biophys. 285, 388-390.
8. Epe B., Pflaum M., Haring M., Hegler J., and Rudger H. (1993) Use of repair endonucleases to characterise DNA damage induced by reactive oxygen species in cellular systems. Toxicol. Lett. 67, 29-39.
9. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease. Evidence supporting it. Ann. Neurol. 32, 804-812.
10. Fraga C. G., Shigenaga M. L., Park J. W., Degan P., and Ames B. N. (1990) Oxidative damage to DNA during ageing: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 87, 4533-4537.
11. Halliwell B. (1996) Oxidative stress, nutrition and health. Experimental strategies for optimisation of nutritional antioxidant intake in humans. Free Radic. Res. 25, 57-74.
12. Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 75-87.
13. Hayakawa M., Torri K., Sugiyama S., Tanaka M., and Ozawa T. (1991) Age-associated accumulation of 8-hydroxy-2′-deoxyguanosine in mitochondrial DNA of human diaphragm. Biochem. Biophys. Res. Commun. 179, 1023-1029.
14. Hayakawa M., Hattori K., Sugiyama S., and Ozawa T. (1992) Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem. Biophys. Res. Commun. 189, 979-985.
15. Jenner P. (1994) Oxidative damage in neurodegenerative disease. Lancet 344, 797-798.
16. Kalra J., Rajput A. H., Mantha S. V., and Prasad K. (1992) Serum antioxidant enzyme activity in Parkinson's disease. Mol. Cell. Biochem. 110, 165-168.
17. Kilinc A., Yalcin A. S., Yalcin D., Taga Y., and Emerk K. (1988) Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease. Neurosci. Lett. 87, 307-310.
18. Mecocci P., Macgarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C., and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609-616.
19. Olanow C. W. (1990) Oxidation reactions in Parkinson's disease. Neurology 40, 32-37.
20. Perry T. L. and Young V. W. (1986) Idiopathic Parkinson's disease, progressive supra-nuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67, 269-274.
21. Ravanat J. L., Turesky R. J., Gremaud E., Trudel L. J., and Stadler R. H. (1995) Determination of 8-oxoguanine in DNA by GC/MS and HPLC-electrochemical detection: overestimation of the background level of the oxidised base by the GC/MS assay. Chem. Res. Toxicol. 8, 1039-1045.
22. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
23. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53, 692-697.
24. Sanchez-Ramos J. R., Overvik E., and Ames B. N. (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 3, 197-204.
25. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
26. Schapira A. H. V., Holt I. J., Sweeney M., Harding A. E., Jenner P., and Marsden C. D. (1990b) Mitochondrial DNA analysis in Parkinson's disease. Mov. Disord. 5, 294-297.
27. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C. D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
28. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G. P., Hebenstreit G., and Youdim M.B.H. (1988) Increased iron (III) and total iron content in post-mortem substantia nigra of parkinsonian brain. J. Neural Transm. 74, 199-205.
29. Sofic E., Lange K. W., Jellinger K., and Riederer P. (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142, 128-130.
30. Spencer J. P. E., Jenner A., Aruoma O. I., Evans P. J., Kaur H., Dexter D. T., Jenner P., Lees A. J., Marsden D. C., and Halliwell B. (1994) Intense oxidative DNA-damage promoted by L-Dopa and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 353, 246-250.
31. Spencer J. P. E., Jenner P., and Halliwell B. (1995) Superoxide-dependent depletion of reduced glutathione by L-Dopa and dopamine. Relevance to Parkinson's disease. Neuroreport 6, 1480-1484.
32. Spencer J. P. E., Wong J., Jenner A., Aruoma O. I., Cross C. E., and Halliwell B. (1996) Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Chem. Res. Toxicol. 9, 1152-1158.
33. Thierry D., Bianchinni F., and Cadet J. (1996) Observation and prevention of an artefactual formation of oxidised DNA bases and nucleosides in the GC-EIMS method. Carcinogenesis 17, 347-353.
34. Vandenakker E., Lutgerink J. T., Lafleur M. V. M., Joenje H., and Retel J. (1994) The formation of one-G deletions as a consequence of singlet-oxygen-induced DNA-damage. Mutat. Res. 309, 45-52.